Search results for "Rigaku Analytical Devices"

The importance of good secondary antibodies in understanding the effects of drug delivery vehicles

Total RNA Extraction from Rhizobium etli Cell or Bacteroid Pellets

Normalization of DNA and RNA Samples with PIPETMAX® Normalization Assistant

Rapid drug screening for safer roads is in your hands

The LumiraDx HbA1c test is an easy to use, fast microfluidic immunoassay designed to rapidly quantify HbA1c in fingerstick and venous whole blood. Used with the LumiraDx Platform, the LumiraDx HbA1c test delivers rapid, reliable results in approximately < 7 minutes at the point of care.

iFuge M15k is equipped with lightning fast 15000 RPM microprocessor that can perform at peak efficiency and give desired results. It gives smooth and silent operation even at the maximum speed.

Perform high-speed separations simply in shared lab settings with the Thermo Scientific™ Sorvall™ LYNX 4000 superspeed centrifuges.

Bio-Rad’s growing range of anti-idiotypic antibodies offers researchers enhanced flexibility for the development of custom bioanalytical drug assays

Acquisition enables Sartorius to continue to develop optimized systems for membrane-based chromatography technology

Sartorius acquires a majority stake in ALS Automated Lab Solutions

The new MDx system will efficiently access a wide array of Seegene's syndromic assays

Explore the latest science and technology advancements in regenerative medicine, COVID-19 diagnostic testing, cardiovascular treatments, point-of-care and more

For a chance to win a $500/£400/450€ Amazon Gift Card, cast your vote for the new products which have made the most difference to clinical diagnostics

The partnership launches RoosterBio’s first international platform with off-the-shelf working cell banks and hMSC bioprocess media products in Asia

Features water-based testing strips and handheld reader delivering convenience and accuracy

Bio-Rad Laboratories has launched a range of anti-certolizumab pegol inhibitory antibodies to support the development of anti-drug antibody (ADA) assays

Special licensing terms enable rapid access to CHOSOURCE platform to streamline SARS-CoV-2 therapeutic development and production processes